Mirror Biologics and Merck KGaA Collaborate on Phase II Trial for Colorectal Cancer Immunotherapy
US-based Mirror Biologics, Inc., an off-the-shelf immunotherapy developer, has announced a clinical trial collaboration and...
Johnson & Johnson’s Posdinemab Receives FDA Fast Track Designation for Alzheimer’s Disease
US giant Johnson & Johnson (J&J, NYSE: JNJ) has announced that it has received Fast...
Boston Scientific Set to Acquire Bolt Medical for Up to USD 900 Million
US major Boston Scientific Corporation (NYSE: BSX) is set to acquire Bolt Medical, Inc., a...
China’s Central Committee and State Council Outline Reforms for Elderly Care Services
The Communist Party of China (CPC) Central Committee and State Council have released the Opinions...
Xtalpi’s Ailux Biologics Partners with UCB for AI-Driven Drug Discovery
Shenzhen-based QuantumPharm Inc. (HKG: 2228), better known as Xtalpi Inc., has announced that its subsidiary...
Shanghai Opens Door to Wholly Foreign-Owned Hospitals in Key Areas
The Shanghai Municipal Health Commission, along with three other bureaus, has jointly released the “Work...
NHSA Strengthens Medical Security Rights for Workers in China
China’s National Healthcare Security Administration (NHSA) has released the “Notice on Further Strengthening the Protection...
Duality Biologics and Avenzo Ink Exclusive License for DB-1418/AVZO-1418
On January 8, Duality Biologics, Inc. (Duality Bio) and Avenzo Therapeutics, Inc. (Avenzo) jointly announced...
MSD’s Gardasil Vaccine Gains NMPA Approval for Use in Males Aged 9 to 26
US major Merck, Sharp & Dohme (MSD; NYSE: MRK) has announced that it has received...
Bayer’s Nubeqa Seeks NMPA Approval for New Prostate Cancer Indication
Bayer AG (ETR: BAYN) has announced the submission of a supplemental new drug application (sNDA)...
GE Healthcare’s Allia IGS Pulse Receives NMPA Clearance for Launch in China
US medical device and life sciences giant GE Healthcare Technologies Inc. (NASDAQ: GEHC) has announced...
Avenzo Therapeutics Licenses Duality Biologics’ EGFR/HER3 Bispecific ADC AVZO-1418/DB-1418
US-based oncology-focused biotech Avenzo Therapeutics, Inc. has signed a licensing agreement with Duality Biologics, an...
Inceptor Bio and GRIT Biotechnology Partner to Advance CAR-T Therapy IB-T101 for Solid Tumors
US-based Inceptor Bio has entered into a partnership with Chinese firm GRIT Biotechnology to advance...
Kexing and Kelun Partner to Expand Overseas Business for Generic Drugs and Therapies
China-based firms Kexing Pharmaceutical (SHA: 688136) and Sichuan Kelun Pharmaceutical Co., Ltd (SHE: 002422) have...
PKU 1st Hospital Partners with Baheal Pharmaceutical on Integrin-Targeted Inhibitor Project
Peking University First Hospital (PKU 1st Hospital) has partnered with China-based health services and distribution...
Takeda and Fudan University’s IMI Launch AI-Based Rare Disease Screening and Diagnosis Project
Japan-headquartered Takeda (TYO: 4502) and the Intelligent Medicine Institute (IMI) at Fudan University have jointly...
LinkedCare Raises Hundreds of Millions in Series E Funding Led by State-Owned Investors
LinkedCare, a consumer healthcare SaaS+ supply chain platform based in Shanghai, has reportedly raised “hundreds...
Grand Life Sciences Partners with Cali Biosciences for CPL-01 Commercialization in China
China-based Grand Life Sciences has entered into a partnership with compatriot firm Cali Biosciences Co.,...
Insilico Medicine’s ISM5411 Shows Positive Results in Phase I Studies for Inflammatory Bowel Disease
China’s generative artificial intelligence (AI)-driven biotech, Insilico Medicine, has announced positive preliminary results from two...
GlycoNex Licenses SPD8 Biosimilar to Undisclosed Company for Osteoporosis Treatment
Taiwan-based GlycoNex, Inc. (TPEx: 4168) has announced a licensing agreement with an undisclosed company for...